Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.

Timothy L FitzgeraldJimmy T EfirdNelly BellamySuzanne M RussoCharulata JindalCatalina MosqueraElizabeth G HollidayTithi Biswas

Published in: Cancer (2017)

In this large series of patients with stage II/III resected gastric/GEJ adenocarcinomas from >1500 American College of Surgeons Commission on Cancer-accredited facilities, patients receiving PECT were shown to survive longer than those receiving POCRT. Cancer 2017;123:2909-17. © 2017 American Cancer Society.

Keyphrases

squamous cell
papillary thyroid
patients undergoing
squamous cell carcinoma
cardiac surgery
rectal cancer
acute kidney injury
young adults
childhood cancer
quality improvement